GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹752 Cr | ₹2,186 Cr | ₹-1,560 Cr | ₹1,587 Cr | ₹-177 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹752 Cr |
| Mar2025 | ₹2,186 Cr |
| Mar2024 | ₹-1,560 Cr |
| Mar2023 | ₹1,587 Cr |
| Mar2022 | ₹-177 Cr |
How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹752 Cr | -65.59 | |
| Mar2025 | ₹2,186 Cr | Positive | |
| Mar2024 | ₹-1,560 Cr | Negative | |
| Mar2023 | ₹1,587 Cr | Positive | |
| Mar2022 | ₹-177 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹47,619.8 Cr | 3% | 14.8% | 46.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3% |
14.8% |
46.7% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses